| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Summit Therapeutics Inc. (SMMT) has 10 insiders with recent SEC Form 4 filings, including 13 buys and 5 sells. SMMT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 3.07M | $54.03M | - | |
| Dir | 35.0K | $615.3K | - | |
| Dir | 35.0K | $615.3K | - | |
| Dir | 35.0K | $615.3K | - | |
| Dir | 35.0K | $615.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Zanganeh Mahkam84 | Co-chief Executive Officer | Buy | 23,527,044 | $1.05 | $24,703,396.20 | +215.2% | +30.3% | +210.5% | |
| Mar 7, 2023 | Dhingra Ankur69 | Chief Financial Officer | Buy | 196,362 | $1.05 | $206,180.10 | +514.1% | +34.8% | +250.7% | |
| Mar 6, 2023 | Duggan Robert W76 | Chief Executive Officer | Buy | 376,489,880 | $1.05 | $395,314,374.00 | +214.1% | +33.8% | +264.7% | |
| Aug 16, 2022 | Duggan Robert W76 | Chief Executive Officer | Buy | 94,849,203 | $0.97 | $92,003,726.91 | +140.1% | +4.0% | +76.2% | |
| Aug 16, 2022 | Zanganeh Maky84 | Co-ceo &President | Buy | 5,809,132 | $0.97 | $5,634,858.04 | +122.4% | +4.0% | +76.2% | |
| Aug 16, 2022 | Dhingra Ankur69 | Chief Financial Officer | Buy | 36,215 | $0.97 | $35,128.55 | +90.5% | +4.0% | +76.2% | |
| May 12, 2021 | Duggan Robert W76 | Chief Executive Officer | Buy | 11,365,921 | $5.24 | $59,557,426.04 | +20.2% | +48.1% | -78.4% | |
| May 12, 2021 | Zanganeh Maky84 | Chief Operating Officer | Buy | 389,077 | $5.24 | $2,038,763.48 | +17.3% | +48.1% | -78.4% | |
| Nov 30, 2020 | Powell David Jonathan | Chief Scientific Officer | Sale+OE | 43,282 | $4.41 | $190,693.63 | -100% | - | - | |
| Nov 25, 2020 | Powell David Jonathan | Chief Scientific Officer | Sale+OE | 30,431 | $4.30 | $130,769.74 | -100% | - | - |